Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yayon

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Orthopedics|August 24, 2001
Role of FGF9 and FGF receptor 3 in osteochondroma formationD Robinson, A Hasharoni, A Oganesian, et al.
Clinical Orthopaedics and Related Research|November 5, 1999
Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cellsD Robinson, A Hasharoni, N Cohen, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 27, 2001
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfacesH J Hecht, R Adar, B Hofmann, et al.
Journal of Neurochemistry|June 20, 2001
Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissueY Kruchkova, I Ben-Dror, A Herschkovitz, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 29, 2005
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossificationS Weizmann, A Tong, A Reich, et al.
Experimental Cell Research|June 20, 1998
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2W Roeckl, D Hecht, H Sztajer, et al.
Biochemistry|September 13, 1994
Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesisL Y Li, M Safran, D Aviezer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1E Levi, R Fridman, H Q Miao, et al.
The Journal of Protozoology|November 1, 1983
Stage-dependent effects of chloroquine on Plasmodium falciparum in vitroA Yayon, J A Vande Waa, M Yayon, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Orthopedics|August 24, 2001
Role of FGF9 and FGF receptor 3 in osteochondroma formationD Robinson, A Hasharoni, A Oganesian, et al.
Clinical Orthopaedics and Related Research|November 5, 1999
Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cellsD Robinson, A Hasharoni, N Cohen, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 27, 2001
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfacesH J Hecht, R Adar, B Hofmann, et al.
Journal of Neurochemistry|June 20, 2001
Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissueY Kruchkova, I Ben-Dror, A Herschkovitz, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 29, 2005
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossificationS Weizmann, A Tong, A Reich, et al.
Experimental Cell Research|June 20, 1998
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2W Roeckl, D Hecht, H Sztajer, et al.
Biochemistry|September 13, 1994
Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesisL Y Li, M Safran, D Aviezer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1E Levi, R Fridman, H Q Miao, et al.
The Journal of Protozoology|November 1, 1983
Stage-dependent effects of chloroquine on Plasmodium falciparum in vitroA Yayon, J A Vande Waa, M Yayon, et al.
Pageof 8